Journal of general internal medicine
-
Randomized Controlled Trial
Home Telemonitoring to Reduce Readmission of High-Risk Patients: a Modified Intention-to-Treat Randomized Clinical Trial.
Home telemonitoring has been used with discharged patients in an attempt to reduce 30-day readmissions with mixed results. ⋯ Thirty days of postdischarge telemonitoring may reduce readmissions of high-risk patients.
-
Multicenter Study
Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry.
Venous thrombotic events (VTE) are frequent in COVID-19, and elevated plasma D-dimer (pDd) and dyspnea are common in both entities. ⋯ In hospitalized patients with COVID-19, a pDd value greater than 3.0 μg/ml can be considered to screen VTE and to consider full-dose anticoagulation.
-
Mailed fecal immunochemical testing (FIT) can increase colorectal cancer (CRC) screening rates, including for vulnerable patients, but its cost-effectiveness is unclear. ⋯ Mailed FIT is an effective and cost-effective population health strategy for CRC screening in vulnerable patients.